Agilent Technologies will provide Oxford Gene Technology with oligonucleotide microarrays and SureSelect target enrichment products for use in OGT's next-generation sequencing services, the companies said this week.
The new agreement expands on an earlier pact inked in 2007, in which Agilent agreed to manufacture OGT-designed arrays for the British firm's customers, and OGT became an Agilent-certified service provider for the Santa Clara, Calif.-based life science tools vendor's microarrays. OGT was later certified as a high-throughput services provider, the only such firm to receive such a designation to date (BAN 3/2/2010).
According to OGT CEO Mike Evans, the deal with Agilent is exclusive in that OGT is compelled to offer Agilent arrays or SureSelect target enrichment products "unless the customer's specific requirements cannot be met with the existing Agilent product range."
In a statement, Evans characterized the pact as a "long-term agreement" that "enables OGT to offer its customers Agilent's ... product range at competitive prices within its ... microarray and sequencing services."
OGT introduced its sequencing services offering, called Genefficiency, earlier this year (BAN 5/13/2011). The company offers a menu of arrays for cytogeneticists called CytoSure, all of which are manufactured by Agilent. In addition to DNA arrays, OGT also maintains an internal protein array program that it gained through its acquisition of Sense Proteomic in 2008 (BAN 3/17/2009).
Further terms of the recent agreement were not available.